Menu
Close
|
Regulatory Information |
Date |
| EUA Amendment of ChAdOx1-S[recombinant] Vaxzevria (COVID-19 Vaccine AstraZeneca) | 27 May 2022 |
|
Product Information |
Patient Information |
 For Healthcare Providers |
For Vaccine Recipients |
For more information on reporting side effects, click here.
Civic Drive Filinvest Corporate City
(02) 8857-1900
local 1000
(02) 8842-5635
Copyright © 2023. All Rights Reserved.